Northwestern University, Robert H. Lurie Comprehensive Cancer Center
Northwestern University, Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma | Hemic and Lymphatic Diseases, Lymphadenopathy, Neoplasms by Histologic Type, Sezary syndrome, T-cell non-Hodgkin lymphoma, angioimmunoblastic T-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, mycosis fungoides, neoplasm, primary cutaneous T-cell lymphoma, primary cutaneous T-cell non-Hodgkin lymphoma | Recruiting | Phase 1 | 2026-10-05 | NCT04234048 |